- Fourth Quarter and Full Year 2022 Cannabinoid Revenue Increased 71% and 90%, Respectively; Total Annual Revenue Growth was 16% Year-over-Year - - Steady Cost Reductions and Portugal. | March 30, 2023
A study published in the journal Thorax compares the pulmonary effects of vaping nicotine and cannabis. The study finds that cannabis is more harmful to lung health than nicotine.
Patients with IBD who concurrently use cannabis show a highly significant reduction in inpatient mortality and hospital length of stay and around 25% drop in hospitalization costs.